"Moyamoya Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A noninflammatory, progressive occlusion of the intracranial CAROTID ARTERIES and the formation of netlike collateral arteries arising from the CIRCLE OF WILLIS. Cerebral angiogram shows the puff-of-smoke (moyamoya) collaterals at the base of the brain. It is characterized by endothelial HYPERPLASIA and FIBROSIS with thickening of arterial walls. This disease primarily affects children but can also occur in adults.
| Descriptor ID |
D009072
|
| MeSH Number(s) |
C10.228.140.300.200.600 C10.228.140.300.510.200.737 C14.907.137.615 C14.907.253.123.620 C14.907.253.560.200.737
|
| Concept/Terms |
Moyamoya Disease- Moyamoya Disease
- Progressive Intracranial Occlusive Arteropathy (Moyamoya)
- Moyamoya Syndrome
- Moya-Moya Disease
- Disease, Moya-Moya
- Moya Moya Disease
- Cerebrovascular Moyamoya Disease
Moyamoya Disease, Primary- Moyamoya Disease, Primary
- Disease, Primary Moyamoya
- Moyamoya Diseases, Primary
- Primary Moyamoya Disease
- Primary Moyamoya Diseases
- Moyamoya Disease, Classic
- Classic Moyamoya Disease
- Disease, Classic Moyamoya
|
Below are MeSH descriptors whose meaning is more general than "Moyamoya Disease".
Below are MeSH descriptors whose meaning is more specific than "Moyamoya Disease".
This graph shows the total number of publications written about "Moyamoya Disease" by people in this website by year, and whether "Moyamoya Disease" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2008 | 0 | 3 | 3 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 4 | 1 | 5 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 6 | 1 | 7 |
| 2017 | 5 | 1 | 6 |
| 2018 | 6 | 1 | 7 |
| 2019 | 4 | 1 | 5 |
| 2020 | 9 | 1 | 10 |
| 2021 | 10 | 0 | 10 |
| 2022 | 12 | 1 | 13 |
| 2023 | 7 | 0 | 7 |
| 2024 | 4 | 0 | 4 |
| 2025 | 2 | 0 | 2 |
Below are the most recent publications written about "Moyamoya Disease" by people in Profiles.
-
Measuring cerebrovascular reactivity with breath-hold fMRI in patients with Moyamoya angiopathy: MR perfusion based delay correction significantly improves agreement to [15O]water PET. Neuroradiology. 2025 Aug; 67(8):2121-2129.
-
Heterozygous Pathogenic Variants in SERPINB7 Potentially Associated With Concomitant Moyamoya Angiopathy and Nagashima-Type Palmoplantar Keratoderma. Am J Med Genet A. 2025 Aug; 197(8):e64058.
-
Bilateral STA-MCA bypass for Moyamoya angiopathy associated with severe erythrodermic psoriasis. J Stroke Cerebrovasc Dis. 2024 Nov; 33(11):107997.
-
Update on the anesthesia management in adult patients with moyamoya disease. Curr Opin Anaesthesiol. 2024 Oct 01; 37(5):439-445.
-
Management of moyamoya disease: a review of current and future therapeutic strategies. J Neurosurg. 2024 Oct 01; 141(4):975-982.
-
Risk factors associated with in-hospital complications for pediatric sickle-cell disease-associated moyamoya syndrome: a nationwide cross-sectional study. Childs Nerv Syst. 2024 Jul; 40(7):2109-2114.
-
Prevention of postoperative stroke in pediatric moyamoya patients: a standardized perioperative care protocol. J Neurosurg Pediatr. 2024 02 01; 33(2):185-189.
-
Posterior cerebral territory ischemia in pediatric moyamoya: Surgical techniques and long-term clinical and radiographic outcomes. Childs Nerv Syst. 2024 Mar; 40(3):791-800.
-
Rapidly progressive moyamoya vasculopathy stabilized with immunotherapy in aicardi-goutières syndrome. J Neurol. 2024 02; 271(2):1019-1022.
-
Cilostazol for the management of moyamoya disease: a systematic review of the early evidence, efficacy, safety, and future directions. Neurosurg Focus. 2023 10; 55(4):E9.